Stuart Randle is the Interim President and Chief Executive Officer of Teleflex.

Stuart Randle was named Interim President and Chief Executive Officer of Teleflex on January 8, 2026. Stuart has over 35 years of experience in senior leadership roles at medical device companies and has served on the Teleflex Board of Directors since 2009. He most recently served as Chief Executive Officer for Ivenix, Inc., a medical device company that provides infusion delivery systems, from January 2016 to December 2018. Prior to that, Mr. Randle served as President and Chief Executive Officer of GI Dynamics, a medical device company, for 10 years.

Prior to joining GI Dynamics, Mr. Randle served as Interim Chief Executive Officer of Optobionics Corporation from 2003 to 2004, as Entrepreneur in Residence of Advanced Technology Ventures, a healthcare and information technology venture capital firm, from 2002 to 2003 and was President and Chief Executive Officer of Act Medical from 1998 to 2001. [Earlier in his career, he held various senior management positions with Allegiance Healthcare Corporation and Baxter International Inc.]

He holds a B.S. in Mechanical Engineering from Cornell University and an MBA from the Kellogg School of Management at Northwestern University.